{"title":"Challenges in the Management of Inflammatory Bowel Disease in Children: A Narrative Review.","authors":"Wathsala Hathagoda, Shaman Rajindrajith, Madunil Anuk Niriella","doi":"10.2147/CEG.S557464","DOIUrl":null,"url":null,"abstract":"<p><p>There is a rising prevalence of pediatric inflammatory bowel disease (PIBD) worldwide. This article aims to explore the key issues in managing PIBD and attempts to propose evidence-based recommendations. We reviewed published literature on PIBD, including original research, systematic reviews, meta-analyses, consensus statements, and position papers. The databases searched were PubMed/MEDLINE, Cochrane Library, Web of Science, and Scopus, using terms related to inflammatory bowel disease, colitis, ulcerative colitis, Crohn's disease, children, adolescents, and pediatrics. The selected articles were critically appraised, summarised and incorporated into the review. PIBD presents multifaceted challenges. They include atypical presentations, very early onset cases, growth and nutritional challenges that affect linear development and pubertal progression, pharmacological management issues related to age-specific medication safety and efficacy and timing of surgical interventions. There are impacts on development; psychosocial burden challenges in education, social development, and family dynamics, all crucial in the future of the child. There are also limitations in access to PIBD services with personalised treatment approaches and challenges in transitional care. It is important to identify these unique challenges posed by PIBD and address them in a comprehensive manner in a multidisciplinary approach.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"18 ","pages":"259-275"},"PeriodicalIF":2.6000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12587853/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/CEG.S557464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
There is a rising prevalence of pediatric inflammatory bowel disease (PIBD) worldwide. This article aims to explore the key issues in managing PIBD and attempts to propose evidence-based recommendations. We reviewed published literature on PIBD, including original research, systematic reviews, meta-analyses, consensus statements, and position papers. The databases searched were PubMed/MEDLINE, Cochrane Library, Web of Science, and Scopus, using terms related to inflammatory bowel disease, colitis, ulcerative colitis, Crohn's disease, children, adolescents, and pediatrics. The selected articles were critically appraised, summarised and incorporated into the review. PIBD presents multifaceted challenges. They include atypical presentations, very early onset cases, growth and nutritional challenges that affect linear development and pubertal progression, pharmacological management issues related to age-specific medication safety and efficacy and timing of surgical interventions. There are impacts on development; psychosocial burden challenges in education, social development, and family dynamics, all crucial in the future of the child. There are also limitations in access to PIBD services with personalised treatment approaches and challenges in transitional care. It is important to identify these unique challenges posed by PIBD and address them in a comprehensive manner in a multidisciplinary approach.
在世界范围内,儿童炎症性肠病(PIBD)的患病率正在上升。本文旨在探讨管理PIBD的关键问题,并试图提出基于证据的建议。我们回顾了已发表的关于PIBD的文献,包括原始研究、系统综述、荟萃分析、共识声明和立场文件。检索的数据库包括PubMed/MEDLINE、Cochrane Library、Web of Science和Scopus,检索的术语与炎症性肠病、结肠炎、溃疡性结肠炎、克罗恩病、儿童、青少年和儿科相关。对选定的文章进行了严格的评价、总结并纳入综述。PIBD提出了多方面的挑战。它们包括非典型表现,非常早发病的病例,影响线性发育和青春期进展的生长和营养挑战,与年龄特异性药物安全性和有效性以及手术干预时机相关的药理学管理问题。对发展有影响;教育、社会发展和家庭动态方面的社会心理负担挑战,这些都对儿童的未来至关重要。在获得个性化治疗方法的PIBD服务方面也存在限制,在过渡护理方面也存在挑战。重要的是要确定PIBD带来的这些独特挑战,并以多学科方法全面解决这些挑战。